Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) [clinicaltrials_resource:NCT00132730/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) [clinicaltrials_resource:NCT00132730/outcome/1]
Bio2RDF identifier
NCT00132730/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00132730/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
The modified ITT population in ...... one posttreatment measurement.
The modified intention-to-trea ...... one posttreatment measurement.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Baseline and Treatment Week 12
Baseline and Treatment Weeks 8 and 12
Baseline and Treatment Weeks 8, 10 and 12
Baseline through Treatment Week 12
Pre-dose at Baseline and Treatment Weeks 8, 10 and 12
Predose at Baseline and Treatment Weeks 8, 10 and 12
type [clinicaltrials_vocabulary:type]
alternate
Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1)
@en
identifier
clinicaltrials_resource:NCT00132730/outcome/1
title
FEV1 is a measure, in liters, ...... asurement was carried forward.
@en
type
label
Change From Baseline in Pre-do ...... esource:NCT00132730/outcome/1]
@en